PUBLISHER: KBV Research | PRODUCT CODE: 1335552
PUBLISHER: KBV Research | PRODUCT CODE: 1335552
North America Digital Dose Inhaler Market Size, Share & Industry Trends Analysis Report By Product (Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI)), By Type, By Indication (COPD, Asthma, and Others), By Country and Growth Forecast, 2023 - 2030
The North America Digital Dose Inhaler Market would witness market growth of 19.0% CAGR during the forecast period (2023-2030).
The market is anticipated to be significantly driven by factors such as the increasing geriatric population, the growth of both severe and mild respiratory disorders, the increasing demand for these new generation inhalation devices, the rising need for cost-effective medications, the growing awareness among people about the benefits of generic drugs, etc. Opportunities for the market include increasing investment in research and development, advancing asthma device manufacturing, and providing cost-effective medication for patients.
Government initiatives, including Medicare and Medicaid plans, group association policies, employee policies, and individual insurance policies, influence the market. In addition, the development of connectivity technologies to improve patient medication compliance and assure the administration of the correct dosage and the introduction of new products create lucrative opportunities market actors.
In the United States, millions of individuals suffer from respiratory disease. Over 25 million individuals have asthma. Strategies to reduce environmental triggers, ensure individuals receive the correct medications, and prevent asthma-related hospitalizations. More than 16 million individuals in the United States have COPD (chronic obstructive pulmonary disease), a leading cause of mortality. Strategies to prevent the disease, such as reducing air pollution and assisting smokers to cease, can be crucial for lowering COPD-related fatalities. Also beneficial for the prevention and treatment of other respiratory diseases are interventions tailored to high-risk populations. Asthma and other respiratory diseases are on the rise, increasing the demand for bronchodilators and driving market growth in North America.
The US market dominated the North America Digital Dose Inhaler Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $14,618.3 million by 2030. The Canada market is experiencing a CAGR of 21.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 20.6% during (2023 - 2030).
Based on Product, the market is segmented into Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI). Based on Type, the market is segmented into Branded Medication, and Generic Medication. Based on Indication, the market is segmented into COPD, Asthma, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sensirion AG, Teva Pharmaceuticals Industries Ltd., OPKO Health, Inc., Propeller Health (ResMed, Inc.), Novartis AG, AstraZeneca PLC, Glenmark Pharmaceuticals Limited, Beximco Pharmaceuticals Ltd., GlaxoSmithKline PLC and Mundipharma Deutschland GmbH & Co. KG.
Scope of the Study
Market Segments covered in the Report:
By Product
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
By Type
- Branded Medication
- Generic Medication
By Indication
- COPD
- Asthma
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Sensirion AG
- Teva Pharmaceuticals Industries Ltd.
- OPKO Health, Inc.
- Propeller Health (ResMed, Inc.)
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Beximco Pharmaceuticals Ltd.
- GlaxoSmithKline PLC
- Mundipharma Deutschland GmbH & Co. KG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Digital Dose Inhaler Market, by Product
- 1.4.2 North America Digital Dose Inhaler Market, by Type
- 1.4.3 North America Digital Dose Inhaler Market, by Indication
- 1.4.4 North America Digital Dose Inhaler Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Force Analysis
Chapter 4. Strategies Deployed in Digital Dose Inhaler Market
Chapter 5. North America Digital Dose Inhaler Market by Product
- 5.1 North America Metered Dose Inhaler (MDI) Market by Country
- 5.2 North America Dry Powder Inhaler (DPI) Market by Country
Chapter 6. North America Digital Dose Inhaler Market by Type
- 6.1 North America Branded Medication Market by Country
- 6.2 North America Generic Medication Market by Country
Chapter 7. North America Digital Dose Inhaler Market by Indication
- 7.1 North America COPD Market by Country
- 7.2 North America Asthma Market by Country
- 7.3 North America Others Market by Country
Chapter 8. North America Digital Dose Inhaler Market by Country
- 8.1 US Digital Dose Inhaler Market
- 8.1.1 US Digital Dose Inhaler Market by Product
- 8.1.2 US Digital Dose Inhaler Market by Type
- 8.1.3 US Digital Dose Inhaler Market by Indication
- 8.2 Canada Digital Dose Inhaler Market
- 8.2.1 Canada Digital Dose Inhaler Market by Product
- 8.2.2 Canada Digital Dose Inhaler Market by Type
- 8.2.3 Canada Digital Dose Inhaler Market by Indication
- 8.3 Mexico Digital Dose Inhaler Market
- 8.3.1 Mexico Digital Dose Inhaler Market by Product
- 8.3.2 Mexico Digital Dose Inhaler Market by Type
- 8.3.3 Mexico Digital Dose Inhaler Market by Indication
- 8.4 Rest of North America Digital Dose Inhaler Market
- 8.4.1 Rest of North America Digital Dose Inhaler Market by Product
- 8.4.2 Rest of North America Digital Dose Inhaler Market by Type
- 8.4.3 Rest of North America Digital Dose Inhaler Market by Indication
Chapter 9. Company Profiles
- 9.1 Sensirion AG
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 SWOT Analysis
- 9.2 Teva Pharmaceutical Industries Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 OPKO Health, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 Propeller Health (ResMed, Inc.)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Novartis AG
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Approvals and Trials:
- 9.5.6 SWOT Analysis
- 9.6 AstraZeneca PLC
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Approvals and Trials:
- 9.6.6 SWOT Analysis
- 9.7 Glenmark Pharmaceuticals Limited
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
- 9.8 Beximco Pharmaceuticals Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Research & Development Expenses
- 9.8.4 SWOT Analysis
- 9.9 GlaxoSmithKline PLC (GSK)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Mundipharma Deutschland GmbH & Co. KG
- 9.10.1 Company Overview
- 9.10.2 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 2 North America Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 3 North America Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 4 North America Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 5 North America Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
- TABLE 6 North America Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
- TABLE 7 North America Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
- TABLE 8 North America Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
- TABLE 9 North America Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 10 North America Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 11 North America Branded Medication Market by Country, 2019 - 2022, USD Million
- TABLE 12 North America Branded Medication Market by Country, 2023 - 2030, USD Million
- TABLE 13 North America Generic Medication Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Generic Medication Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 16 North America Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 17 North America COPD Market by Country, 2019 - 2022, USD Million
- TABLE 18 North America COPD Market by Country, 2023 - 2030, USD Million
- TABLE 19 North America Asthma Market by Country, 2019 - 2022, USD Million
- TABLE 20 North America Asthma Market by Country, 2023 - 2030, USD Million
- TABLE 21 North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
- TABLE 24 North America Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
- TABLE 25 US Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 26 US Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 27 US Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 28 US Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 29 US Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 30 US Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 31 US Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 32 US Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 33 Canada Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 34 Canada Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 35 Canada Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 36 Canada Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 37 Canada Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 38 Canada Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 39 Canada Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 40 Canada Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 41 Mexico Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 42 Mexico Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 43 Mexico Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 44 Mexico Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 45 Mexico Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 46 Mexico Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 47 Mexico Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 48 Mexico Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 49 Rest of North America Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 50 Rest of North America Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 51 Rest of North America Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 52 Rest of North America Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 53 Rest of North America Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 54 Rest of North America Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 55 Rest of North America Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 56 Rest of North America Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 57 Key Information - Sensirion AG
- TABLE 58 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 59 Key Information - OPKO Health, Inc.
- TABLE 60 Key Information - Propeller Health
- TABLE 61 Key Information - Novartis AG
- TABLE 62 KEY INFORMATION - AstraZeneca PLC
- TABLE 63 Key Information - Glenmark Pharmaceuticals Limited
- TABLE 64 Key Information - Beximco Pharmaceuticals Ltd.
- TABLE 65 Key Information - GlaxoSmithKline PLC
- TABLE 66 Key Information - Mundipharma Deutschland GmbH & Co. KG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 North America Digital Dose Inhaler Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors digital dose inhaler market
- FIG 4 Porter's Five Force Analysis: Digital Dose Inhaler Market
- FIG 5 North America Digital Dose Inhaler Market share by Product, 2022
- FIG 6 North America Digital Dose Inhaler Market share by Product, 2030
- FIG 7 North America Digital Dose Inhaler Market by Product, 2019 - 2030, USD Million
- FIG 8 North America Digital Dose Inhaler Market share by Type, 2022
- FIG 9 North America Digital Dose Inhaler Market share by Type, 2030
- FIG 10 North America Digital Dose Inhaler Market by Type, 2019 - 2030, USD Million
- FIG 11 North America Digital Dose Inhaler Market share by Indication, 2022
- FIG 12 North America Digital Dose Inhaler Market share by Indication, 2030
- FIG 13 North America Digital Dose Inhaler Market by Indication, 2019 - 2030, USD Million
- FIG 14 North America Digital Dose Inhaler Market share by Country, 2022
- FIG 15 North America Digital Dose Inhaler Market share by Country, 2030
- FIG 16 North America Digital Dose Inhaler Market by Country, 2019 - 2030, USD Million
- FIG 17 SWOT Analysis: SENSIRION AG
- FIG 18 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
- FIG 19 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
- FIG 20 SWOT Analysis: OPKO Health, Inc.
- FIG 21 SWOT Analysis: Propeller Health
- FIG 22 SWOT Analysis: Novartis AG
- FIG 23 SWOT Analysis: AstraZeneca PLC
- FIG 24 SWOT Analysis: Glenmark Pharmaceuticals Ltd.
- FIG 25 SWOT Analysis: Beximco Pharmaceuticals Ltd.
- FIG 26 SWOT Analysis: GlaxoSmithKline PLC
- FIG 27 SWOT Analysis: Mundipharma Deutschland GmbH & Co. KG
